Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusuke Miyazaki

Showing results (201-210 of 217) with videos related to

Pageof 22
Sort By:
Annals of the Rheumatic Diseases|February 7, 2025
Peripheral blood immunophenotypic diversity in patients with rheumatoid arthritis and its impact on therapeutic responsivenessSatoshi Kubo, Yusuke Miyazaki, Takahiro Nishino, et al.
Rheumatology and Therapy|August 9, 2024
Efficacy and Safety of Biologics in Polymyalgia Rheumatica: A Retrospective StudyNaoaki Ohkubo, Yusuke Miyazaki, Shingo Nakayamada, et al.
Rheumatology (Oxford, England)|November 18, 2021
mTOR activation in CD8+ cells contributes to disease activity of rheumatoid arthritis and increases therapeutic response to TNF inhibitorsMingzeng Zhang, Shigeru Iwata, Koshiro Sonomoto, et al.
Circulation|December 28, 2018
Improvement in Outcomes After Cardiac Arrest and Resuscitation by Inhibition of S-Nitrosoglutathione ReductaseKei Hayashida, Aranya Bagchi, Yusuke Miyazaki, et al.
Modern Rheumatology|March 16, 2026
Effectiveness and Safety of Sarilumab in Polymyalgia Rheumatica: a retrospective study of the FIRST RegistryNaoaki Ohkubo, Yusuke Miyazaki, Satoshi Kubo, et al.
Journal of Nutritional Science and Vitaminology|May 22, 2015
Colloidal submicron-particle curcumin exhibits high absorption efficiency-a double-blind, 3-way crossover studyYoichi Sunagawa, Sae Hirano, Yasufumi Katanasaka, et al.
Biosensors & Bioelectronics|May 12, 2023
Mutation detection of urinary cell-free DNA via catch-and-release isolation on nanowires for liquid biopsyHiromi Takahashi, Takao Yasui, Masaki Hirano, et al.
Rheumatology and Therapy|March 2, 2025
Effective Second-Line b/tsDMARDs for Patients with Rheumatoid Arthritis Unresponsive to First-Line b/tsDMARDs from the FIRST RegistryRyuichiro Kanda, Yusuke Miyazaki, Shingo Nakayamada, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 4, 2023
HER-2-Targeted Boron Neutron Capture Therapy with Carborane-integrated Immunoliposomes Prepared via an Exchanging ReactionRiku Kawasaki, Ayano Oshige, Keita Yamana, et al.
RMD Open|May 12, 2026
Real-world effectiveness, safety and patient-reported outcomes of sarilumab in patients with rheumatoid arthritis: a 52-week, prospective, open-label, non-interventional, observational, nationwide, large-cohort study in Japan (PROFILE-J)Yoshiya Tanaka, Kentaro Hanami, Yusuke Miyazaki, et al.
Pageof 22

Showing results (201-210 of 217) with videos related to

Sort By:
Pageof 22
Annals of the Rheumatic Diseases|February 7, 2025
Peripheral blood immunophenotypic diversity in patients with rheumatoid arthritis and its impact on therapeutic responsivenessSatoshi Kubo, Yusuke Miyazaki, Takahiro Nishino, et al.
Rheumatology and Therapy|August 9, 2024
Efficacy and Safety of Biologics in Polymyalgia Rheumatica: A Retrospective StudyNaoaki Ohkubo, Yusuke Miyazaki, Shingo Nakayamada, et al.
Rheumatology (Oxford, England)|November 18, 2021
mTOR activation in CD8+ cells contributes to disease activity of rheumatoid arthritis and increases therapeutic response to TNF inhibitorsMingzeng Zhang, Shigeru Iwata, Koshiro Sonomoto, et al.
Circulation|December 28, 2018
Improvement in Outcomes After Cardiac Arrest and Resuscitation by Inhibition of S-Nitrosoglutathione ReductaseKei Hayashida, Aranya Bagchi, Yusuke Miyazaki, et al.
Modern Rheumatology|March 16, 2026
Effectiveness and Safety of Sarilumab in Polymyalgia Rheumatica: a retrospective study of the FIRST RegistryNaoaki Ohkubo, Yusuke Miyazaki, Satoshi Kubo, et al.
Journal of Nutritional Science and Vitaminology|May 22, 2015
Colloidal submicron-particle curcumin exhibits high absorption efficiency-a double-blind, 3-way crossover studyYoichi Sunagawa, Sae Hirano, Yasufumi Katanasaka, et al.
Biosensors & Bioelectronics|May 12, 2023
Mutation detection of urinary cell-free DNA via catch-and-release isolation on nanowires for liquid biopsyHiromi Takahashi, Takao Yasui, Masaki Hirano, et al.
Rheumatology and Therapy|March 2, 2025
Effective Second-Line b/tsDMARDs for Patients with Rheumatoid Arthritis Unresponsive to First-Line b/tsDMARDs from the FIRST RegistryRyuichiro Kanda, Yusuke Miyazaki, Shingo Nakayamada, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 4, 2023
HER-2-Targeted Boron Neutron Capture Therapy with Carborane-integrated Immunoliposomes Prepared via an Exchanging ReactionRiku Kawasaki, Ayano Oshige, Keita Yamana, et al.
RMD Open|May 12, 2026
Real-world effectiveness, safety and patient-reported outcomes of sarilumab in patients with rheumatoid arthritis: a 52-week, prospective, open-label, non-interventional, observational, nationwide, large-cohort study in Japan (PROFILE-J)Yoshiya Tanaka, Kentaro Hanami, Yusuke Miyazaki, et al.
Pageof 22